Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Shares Outstanding (Weighted Average): 2019-2024

Historic Shares Outstanding (Weighted Average) for Immunocore Holdings (IMCR) over the last 6 years, with Dec 2024 value amounting to $50.0 million.

  • Immunocore Holdings' Shares Outstanding (Weighted Average) rose 0.74% to $50.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.4 million, marking a year-over-year increase of 0.74%. This contributed to the annual value of $50.0 million for FY2024, which is 1.20% up from last year.
  • Latest data reveals that Immunocore Holdings reported Shares Outstanding (Weighted Average) of $50.0 million as of FY2024, which was up 1.20% from $49.4 million recorded in FY2023.
  • Immunocore Holdings' 5-year Shares Outstanding (Weighted Average) high stood at $50.0 million for FY2024, and its period low was $40.7 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $49.4 million (2023), whereas its average is $49.1 million.
  • Data for Immunocore Holdings' Shares Outstanding (Weighted Average) shows a peak YoY climbed of 9.22% (in 2022) over the last 5 years.
  • Over the past 5 years, Immunocore Holdings' Shares Outstanding (Weighted Average) (Yearly) stood at $40.7 million in 2020, then climbed by 7.66% to $43.9 million in 2021, then increased by 9.22% to $47.9 million in 2022, then grew by 3.20% to $49.4 million in 2023, then climbed by 1.20% to $50.0 million in 2024.